Anika Therapeutics Inc.Anika Therapeutics Inc.Anika Therapeutics Inc.

Anika Therapeutics Inc.

No trades
See on Supercharts

ANIK fundamentals

Anika Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ANIK for the last quarter is 38.75 M USD, and it's 7.56% lower compared to the previous quarter. The net income of Q3 24 is -29.92 M USD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth